Daily News Podcast

Bisphosphonate holiday reduces risk of atypical femur fracture

Publish date: October 10, 2018

 

A holiday from bisphosphonates may help reduce atypical femur fracture risk. Also today, most dermatologic drugs are safe for breastfeeding mothers, impressive HbA1c and weight control from a new novel drug, and short-term NSAIDs appear safe for high-risk patients.

Recommended Reading

Get on top of home BP monitoring
MDedge Rheumatology
Researchers share Nobel Prize for cancer immunotherapy discoveries
MDedge Rheumatology
Aspirin for the elderly: what to do
MDedge Rheumatology
Neurological disease and aging
MDedge Rheumatology
PCV13 for older adults
MDedge Rheumatology
Sexual assault, harassment linked to depression
MDedge Rheumatology
How to vaccinate patients on biologics
MDedge Rheumatology
Allopurinol reduces risk of renal decline in gout patients
MDedge Rheumatology
9-valent HPV vaccine approved for 27-45 age group
MDedge Rheumatology
Outpatients antibiotics and disease codes
MDedge Rheumatology